BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14963286)

  • 41. Harmonic imaging with Levovist.
    Schwarz KQ; Chen X; Steinmetz S; Phillips D
    J Am Soc Echocardiogr; 1997; 10(1):1-10. PubMed ID: 9046488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Harmonic imaging. A new method of ultrasound imaging of brain perfusion].
    Seidel G; Meyer K
    Nervenarzt; 2001 Aug; 72(8):600-9. PubMed ID: 11519200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perfusion imaging of high-grade gliomas: a comparison between contrast harmonic and magnetic resonance imaging. Technical note.
    Harrer JU; Möller-Hartmann W; Oertel MF; Klötzsch C
    J Neurosurg; 2004 Oct; 101(4):700-3. PubMed ID: 15481731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcranial duplex ultrasound: experience with contrast enhancing agents.
    Bauer A; Becker G; Henz P; Jachimczak P; Schwarz KQ; Haase A; Bogdahn U
    Int Angiol; 1997 Dec; 16(4):216-21. PubMed ID: 9543216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes of contrast-specific ultrasonic cerebral perfusion patterns in the course of stroke; reliability of region-wise and parametric imaging analysis.
    Eyding J; Nolte-Martin A; Krogias C; Postert T
    Ultrasound Med Biol; 2007 Mar; 33(3):329-34. PubMed ID: 17207904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic transcranial ultrasound perfusion-imaging at 2.5 MHz does not affect the blood-brain barrier.
    Jungehulsing GJ; Brunecker P; Nolte CH; Fiebach JB; Kunze C; Doepp F; Villringer A; Schreiber SJ
    Ultrasound Med Biol; 2008 Jan; 34(1):147-50. PubMed ID: 17854981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Morimoto M; Shirato K; Sugimori K; Kokawa A; Tomita N; Saito T; Imada T; Tanaka N; Nozawa A; Numata K; Tanaka K
    AJR Am J Roentgenol; 2003 Jul; 181(1):65-9. PubMed ID: 12818831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contrast-enhanced transcranial two-dimensional ultrasound imaging using shear-mode conversion at low frequency.
    Lucht B; Hubbell A; Hynynen K
    Ultrasound Med Biol; 2013 Feb; 39(2):332-44. PubMed ID: 23245822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of flow rates using harmonic grey-scale imaging and an ultrasound contrast agent: an in vitro and in vivo study.
    Claassen L; Seidel G; Algermissen C
    Ultrasound Med Biol; 2001 Jan; 27(1):83-8. PubMed ID: 11295274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gray-scale second harmonic imaging of the liver with galactose-based microbubbles.
    Kono Y; Moriyasu F; Mine Y; Nada T; Kamiyama N; Suginoshita Y; Matsumura T; Kobayashi K; Chiba T
    Invest Radiol; 1997 Feb; 32(2):120-5. PubMed ID: 9039585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcranial contrast diminution imaging of the human brain: a pilot study in healthy volunteers.
    Meyer K; Seidel G
    Ultrasound Med Biol; 2002; 28(11-12):1433-7. PubMed ID: 12498938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Semiquantitative human cerebral perfusion assessment with ultrasound in brain space-occupying lesions: preliminary data.
    Vicenzini E; Delfini R; Magri F; Puccinelli F; Altieri M; Santoro A; Giannoni MF; Bozzao L; Di Piero V; Lenzi GL
    J Ultrasound Med; 2008 May; 27(5):685-92. PubMed ID: 18424642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcranial shear-mode ultrasound: assessment of imaging performance and excitation techniques.
    Yousefi A; Goertz DE; Hynynen K
    IEEE Trans Med Imaging; 2009 May; 28(5):763-74. PubMed ID: 19150789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
    Jung EM; Clevert DA; Rupp N
    Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contrast-enhanced transcranial imaging. Results of an American phase-two study.
    Otis S; Rush M; Boyajian R
    Stroke; 1995 Feb; 26(2):203-9. PubMed ID: 7831688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.
    Furuse J; Nagase M; Ishii H; Yoshino M
    Br J Radiol; 2003 Jun; 76(906):385-92. PubMed ID: 12814924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Harmonic imaging of the brain parenchyma using a perfluorobutane-containing ultrasound contrast agent.
    Seidel G; Meyer K; Algermissen C; Broillet A
    Ultrasound Med Biol; 2001 Jul; 27(7):915-8. PubMed ID: 11476924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wideband harmonic imaging: a novel contrast ultrasound imaging technique.
    Bauer A; Hauff P; Lazenby J; von Behren P; Zomack M; Reinhardt M; Schlief R
    Eur Radiol; 1999; 9 Suppl 3():S364-7. PubMed ID: 10602930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [3-dimensional echo-enhanced transcranial Doppler ultrasound diagnosis].
    Bauer A; Bogdahn U; Haase A; Schlief R
    Radiologe; 1998 May; 38(5):394-8. PubMed ID: 9646346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.